Clinical Trials Browser

Phase 2 × Pathologic Complete Response × Cisplatin × Clear all

NCT04781725 2021-11-17

INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast Cancer

Phase 2 Unknown

Pathologic Complete Response, Breast Neoplasms